Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax

Microbes and Infection

Volumn 9, Issue 12-13, 2007, Pages 1478-1483

  Klinman, Dennis M ^a   Currie, Debra ^a   Lee, Gloria ^b   Grippe, Vanessa ^b   Merkel, Tod ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Anthrax; Protection; Vaccine

Indexed keywords

ANTHRAX VACCINE; CPG OLIGODEOXYNUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; INFECTION PREVENTION; MOUSE; MOUSE STRAIN; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CPG ISLANDS; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INJECTIONS, INTRAPERITONEAL; MICE; OLIGODEOXYRIBONUCLEOTIDES; VACCINATION;

MUS;

EID: 35548947142     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.08.002     Document Type: Article

References (28)

1. Hanna P. Anthrax pathogenesis and host response. Curr. Top. Microbiol. Immunol. 225 (1998) 13-35
2. Quinn C.P., and Turnbull P.C. Anthrax. In: Ballow M., and Sussman M. (Eds). Topley and Wilson's Microbiology and Microbial Infections (1998), Collier, London 799-818
3. Fritz D.L., Jaax N.K., Lawrence W.B., Davis K.J., Pitt M.L., Ezzell J.W., and Friedlander A.M. Pathology of experimental inhalation anthrax in the rhesus monkey. Lab. Invest. 73 (1995) 691-702
4. Zaucha G.M., Pitt L.M., Estep J., Ivins B.E., and Friedlander A.M. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch. Pathol. Lab. Med. 122 (1998) 982-992
5. Lane H.C., Montagne J.L., and Fauci A.S. Bioterrorism: a clear and present danger. Nat. Med 7 (2001) 1271-1273
6. Ivins B.E., and Welkos S.L. Recent advances in the development of an improved, human anthrax vaccine. Eur. J. Epidemiol. 4 (1998) 12-19
7. Ivins B.E., Welkos S.L., Little S.F., Crumrine M.H., and Nelson G.O. Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants. Infect. Immun. 60 (1992) 662-668
8. Little S.F., and Ivins B.E. Molecular pathogenesis of Bacillus anthracis infection. Microbes Infect. 1 (1999) 131-139
9. Welkos S., Little S.F., Friedlander A.M., Fritz D., and Fellows P. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology 147 (2001) 1677-1685
10. Welkos S.L., and Friedlander A.M. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice. Microb. Pathol. 5 (1998) 127-139
11. Pittman P.R., Gibbs P.H., Cannon T.L., and Friedlander A.M. Anthrax vaccine: short-term safety experience in humans. Vaccine 12 (2001) 972-978
12. Ready T. US soldiers refuse to fall in line with anthrax vaccination scheme. Nat. Med. 10 (2004) 112
13. Geier D.A., and Geier M.R. Anthrax vaccination and joint related adverse reactions in light of biological warfare scenarios. Clin. Exp. Rheumatol. 20 (2002) 217-220
14. Jones T.R., Obaldia N., Gramzinski R.A., Charoenvit Y., Kolodny N., Kitov S., et al. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenic vaccine in Aotus monkeys. Vaccine 17 (1999) 3065-3071
15. Davis H.L., Suparto I.L., Weeratna R.R., Junintarto D.D., Chamzah S.S., Ma'ruf A.A., et al. CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans. Vaccine 18 (2000) 1920-1924
16. Klinman D.M., Xie H., Little S.F., Currie D., and Ivins B.E. CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques. Vaccine 22 (2004) 2881-2886
17. Klinman D.M., Yi A., Beaucage S.L., Conover J., and Krieg A.M. CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFNg. Proc. Natl. Acad. Sci. USA 93 (1996) 2879-2883
18. Krieg A.M., Yi A., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-548
19. Xie H., Gursel I., Ivins B.E., Singh M., O'Hagan D.T., Ulmer J.B., et al. CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine. Infect. Immun 73 (2005) 828-833
20. Ivins B.E., Pitt M.L., Fellows P.F., Farchaus J.S., Benner G.E., Waag D.M., et al. Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques. Vaccine 16 (1998) 1141-1148
21. Dixon T.C., Meselson M., Guillemin J., and Hanna P.C. Anthrax. N. Engl. J. Med 341 (1999) 815-826
22. Grewal H.M., Hemming K.T., Vetvik H., Ahr M.C., Gjessing H.K., Sommerfelt H., et al. Measurement of specific IgA in faecal extracts and intestinal lavage fluid for monitoring of mucosal immune responses. J. Immunol. Methods 239 (2000) 53-62
23. Pickering A.K., Osorio M., Lee G.M., Grippe V.K., Bray M., and Merkel T.J. Cytokine response to infection with Bacillus anthracis spores. Infect. Immun. 72 (2004) 6382-6389
24. Harvill E.T., Lee G., Grippe V.K., and Merkel T.J. Complement depletion renders C57BL/6 mice sensitive to the Bacillus anthracis Sterne strain. Infect. Immun. 73 (2005) 4420-4422
25. Heckert R.A., Saif L.J., Mengel J.P., and Myers G.W. Isotype-specific antibody responses to bovine coronavirus structural proteins in serum, feces, and mucosal secretions from experimentally challenge-exposed colostrum-deprived calves. Am. J. Vet. Res. 52 (1991) 692-699
26. Garcia-Diaz A., Lopez-Andujar P., Rodriguez D.J., Montava R., Torres B.C., Ribes J.M., et al. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies. Vaccine 23 (2004) 489-498
27. Rynkiewicz D., Rathkopf M., Ransom J., Sim I., Giri L., Quinn J., et al. Marked enhancement of antibody response to anthrax vaccine adsorbed with CpG 7909 in healthy volunteers. ICAAC abstract LB-25 (2005)
28. Jefferds M.D., Laserson K., Fry A.M., Roy S., Hayslett J., Grummer-Strawn L., et al. Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, DC in 2001,. Emerg. Infect. Dis 8 (2002) 1138-1144